youtube profile pic.png
Pain Management Therapeutics Market is Expected to Surpass USD 97.23 Billion by 2028 at a CAGR of 4.3% from 2022-2028; Rising Prevalence of Chronic Pain Conditions and Demand for Pain Management Drugs to Boost Market Growth
14 mars 2023 21h30 HE | SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA,, March 14, 2023 (GLOBE NEWSWIRE) -- The pain management therapeutics market is rapidly growing globally, with North America expected to take the lead position. This is due to the...
Logo.jpg
Endonovo Announces Distribution Agreement with Academy Medical
06 mars 2023 09h07 HE | Endonovo Therapeutics, Inc.
Provide Improved Medical Services to VHA and U.S. Dept. of Defense Los Angeles, CA, March 06, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the signing of a...
Logo.jpg
Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg
28 févr. 2023 09h09 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), a medical device company specializing in pulsed electromagnetic field (PEMF) technology, announced today...
Global Paracetamol IV Market
Global Paracetamol IV Market Research Report to 2030 - Enhanced Usage of Acetaminophen to Reduce the Dependence on Opioids for Pain Management Drives Growth
23 févr. 2023 11h33 HE | Research and Markets
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Paracetamol IV Market Research Report by Indication (Pain and Pyrexia/Fever), Application, End-use, Region - Cumulative Impact of COVID-19, Russia...
SPR Therapeutics LOGO 361 TM.jpg
SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an Expanded Intended Patient Population for the SPRINT® PNS System
03 févr. 2023 15h32 HE | SPR Therapeutics, Inc.
CLEVELAND, Feb. 03, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic...
22157.jpg
Lidocaine Ointment Market Report 2022: Featuring Glenmark Pharmaceuticals, Novocol Pharma, AstraZeneca & More
16 janv. 2023 09h33 HE | Research and Markets
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Lidocaine Ointment Market, by Formulation, by Age Group, by Application, by Distribution Channel, by Region - Size, Share, Outlook, and Opportunity...
22157.jpg
Analgesics Global Market Report 2022: Sector to Reach $56.86 Million by 2030 at a CAGR of 4.9%
10 janv. 2023 05h18 HE | Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Analgesics Market by Type and by Route of Administration - Global Opportunity Analysis and Industry Forecast 2022-2030" report has been added to ...
Logo.jpg
Endonovo Therapeutics Details Plan to Spin Off Medical Device Division as a Listed Public Company
09 janv. 2023 09h03 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) today announced details for its plan to spin off its current medical device division, known as NewCo, as a...
ZetrOZ presents at the MLB winter meetings to PBATS
ZetrOZ Systems Hosts Lunch and Lecture for the Professional Baseball Athletic Trainers Society
05 janv. 2023 10h31 HE | ZetrOZ Systems
SAN DIEGO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ZetrOZ Systems hosted a Lunch and Lecture for The Professional Baseball Athletic Trainers Society (PBATS) during the Major League Baseball Winter...
Logo.jpg
Endonovo Announces Advancement of International “Go to Market” Initiative
19 déc. 2022 09h09 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced an aggressive initiative to introduce and develop the sales and benefits of SofPulse®...